• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝外胆管癌上皮内扩散的新见解:382例肝外胆管癌的临床病理研究

Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma.

作者信息

Nagashima Daisuke, Esaki Minoru, Nara Satoshi, Ban Daisuke, Takamoto Takeshi, Mizui Takahiro, Shimada Kazuaki, Hiraoka Nobuyoshi

机构信息

Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.

Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Front Oncol. 2023 Aug 17;13:1216097. doi: 10.3389/fonc.2023.1216097. eCollection 2023.

DOI:10.3389/fonc.2023.1216097
PMID:37664071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10470634/
Abstract

BACKGROUND

Extrahepatic cholangiocarcinoma (eCCA) is a rare and aggressive disease and consisted of conventional eCCA and intraductal papillary neoplasm of the bile duct (IPNB). Intraepithelial spread (IES) of cancer cells beyond the invasive area is often observed in IPNBs; however, the prevalence of IES remains to be examined in conventional eCCAs. Here, we evaluated the clinicopathological features of eCCAs according to tumor location, with a focus on the presence of IES. The IES extension was also compared among biliary tract cancers (BTCs).

METHODS

We examined the prevalence and clinicopathological significance of IES in eCCAs (n=382) and the IES extension of BTCs, including gallbladder (n=172), cystic duct (n=20), and ampullary cancers (n=102).

RESULTS

Among the invasive eCCAs, IPNB had a higher rate of IES (89.2%) than conventional eCCAs (57.0%). Among conventional eCCAs, distal eCCAs (75.4%) had a significantly higher prevalence of IES than perihilar eCCAs (41.3%). The presence of IES was associated with a significantly higher survival rate in patients with distal eCCAs (=0.030). Extension of the IES into the cystic duct (CyD) in distal eCCAs that cancer cells reached the junction of the CyD was a favorable prognostic factor (<0.001). The association of survival with IES, either on the extrahepatic bile duct or on the CyD, differed depending on the tumor location and type of eCCA. The extension properties of IES were also dependent on different types of tumors among BTCs; usually, the IES incidence became higher than 50% in the tissues that the tumor developed, whereas IES extension to other tissues decreased the incidence.

CONCLUSION

Thus, eCCAs have different clinicopathological characteristics depending on the tumor location and type.

摘要

背景

肝外胆管癌(eCCA)是一种罕见且侵袭性强的疾病,包括传统型eCCA和胆管内乳头状肿瘤(IPNB)。在IPNB中常观察到癌细胞超出浸润区域的上皮内扩散(IES);然而,传统型eCCAs中IES的发生率仍有待研究。在此,我们根据肿瘤位置评估了eCCAs的临床病理特征,重点关注IES的存在情况。还比较了胆道癌(BTCs)中IES的扩展情况。

方法

我们研究了eCCAs(n = 382)中IES的发生率及其临床病理意义,以及BTCs(包括胆囊癌,n = 172;胆囊管癌,n = 20;壶腹癌,n = 102)的IES扩展情况。

结果

在浸润性eCCAs中,IPNB的IES发生率(89.2%)高于传统型eCCAs(57.)。在传统型eCCAs中,远端eCCAs的IES发生率(75.4%)显著高于肝门周围eCCAs(41.3%)。IES的存在与远端eCCAs患者的生存率显著较高相关(P = 0.030)。在癌细胞到达胆囊管交界处的远端eCCAs中,IES扩展至胆囊管是一个有利的预后因素(P < 0.001)。IES与肝外胆管或胆囊管的生存关联因eCCA的肿瘤位置和类型而异。IES的扩展特性在不同类型的BTCs中也有所不同;通常,在肿瘤发生的组织中IES发生率高于50%,而IES扩展至其他组织则会降低发生率。

结论

因此,eCCAs根据肿瘤位置和类型具有不同的临床病理特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/971fb8392427/fonc-13-1216097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/6edab28ea665/fonc-13-1216097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/122bc9257ac7/fonc-13-1216097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/346fecdf5a61/fonc-13-1216097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/1203d1678037/fonc-13-1216097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/971fb8392427/fonc-13-1216097-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/6edab28ea665/fonc-13-1216097-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/122bc9257ac7/fonc-13-1216097-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/346fecdf5a61/fonc-13-1216097-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/1203d1678037/fonc-13-1216097-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bacf/10470634/971fb8392427/fonc-13-1216097-g005.jpg

相似文献

1
Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma.肝外胆管癌上皮内扩散的新见解:382例肝外胆管癌的临床病理研究
Front Oncol. 2023 Aug 17;13:1216097. doi: 10.3389/fonc.2023.1216097. eCollection 2023.
2
Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".关于“胆管内乳头状肿瘤(IPNB)”的所谓“具有导管内乳头状生长的胆管癌”的临床病理特征
Int J Clin Exp Pathol. 2014 May 15;7(6):3112-22. eCollection 2014.
3
Development of extrahepatic bile ducts and mechanisms of tumorigenesis: Lessons from mouse models.肝外胆管的发育和肿瘤发生机制:来自小鼠模型的启示。
Pathol Int. 2022 Dec;72(12):589-605. doi: 10.1111/pin.13287. Epub 2022 Nov 9.
4
Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.肿瘤位置对胆管内乳头状瘤术后结局的影响
World J Surg. 2019 May;43(5):1313-1322. doi: 10.1007/s00268-019-04913-3.
5
Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.胆管内乳头状肿瘤与乳头状胆管癌的临床病理对照研究
Histopathology. 2016 Dec;69(6):950-961. doi: 10.1111/his.13037. Epub 2016 Sep 23.
6
Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.胆管内乳头状肿瘤的临床病理特征:一项日-韩合作研究。
J Hepatobiliary Pancreat Sci. 2020 Sep;27(9):581-597. doi: 10.1002/jhbp.785. Epub 2020 Jul 2.
7
Epidemiology and outcome of individuals with intraductal papillary neoplasms of the bile duct.胆管导管内乳头状肿瘤患者的流行病学及预后
World J Gastrointest Oncol. 2023 May 15;15(5):843-858. doi: 10.4251/wjgo.v15.i5.843.
8
The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.基质金属蛋白酶在肝内胆管癌、肝门部(克氏壶腹肿瘤)、肝外胆管中下段癌、胆囊癌和壶腹癌中的表达:基质金属蛋白酶在肿瘤进展和预后中的作用
Turk J Gastroenterol. 2009 Mar;20(1):41-7.
9
Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.胆管内乳头状肿瘤在职业性胆管癌患者中的发展。
Virchows Arch. 2023 Apr;482(4):745-753. doi: 10.1007/s00428-023-03499-5. Epub 2023 Jan 30.
10
PD-L1 expression in extrahepatic cholangiocarcinoma.PD-L1 在外周型胆管癌中的表达。
Histopathology. 2017 Sep;71(3):383-392. doi: 10.1111/his.13238. Epub 2017 Jun 23.

引用本文的文献

1
Current considerations on intraductal papillary neoplasms of the bile duct and pancreatic duct.当前关于胆管和胰管内乳头状肿瘤的考虑因素。
World J Gastroenterol. 2024 Mar 14;30(10):1461-1465. doi: 10.3748/wjg.v30.i10.1461.

本文引用的文献

1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.辅助 S-1 对比观察用于可切除胆管癌(JCOG1202,ASCOT):一项多中心、开放标签、随机、对照、III 期临床试验。
Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Association between the expression of core 3 synthase and survival outcomes of patients with cholangiocarcinoma.
核心3合酶表达与胆管癌患者生存结局之间的关联。
Oncol Lett. 2021 Nov;22(5):760. doi: 10.3892/ol.2021.13021. Epub 2021 Sep 3.
4
Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma.定义根治性切除术后远端胆管癌早期复发的风险。
Ann Surg Oncol. 2021 Aug;28(8):4205-4213. doi: 10.1245/s10434-021-09811-4. Epub 2021 Mar 11.
5
Biliary tract cancer.胆道癌。
Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7.
6
Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer.454 例胆道癌中人类表皮生长因子受体 2 状态的详细信息。
Hum Pathol. 2020 Nov;105:9-19. doi: 10.1016/j.humpath.2020.08.006. Epub 2020 Sep 3.
7
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.全球范围内 1993 年至 2012 年内肝内和肝外胆管癌发病率的变化趋势。
Cancer. 2020 Jun 1;126(11):2666-2678. doi: 10.1002/cncr.32803. Epub 2020 Mar 4.
8
The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location.肝外胆管癌中胃肠道分化标志物的表达:基于肿瘤位置的临床病理意义。
Hum Pathol. 2019 Oct;92:91-100. doi: 10.1016/j.humpath.2019.08.002. Epub 2019 Aug 8.
9
Development of the Intrahepatic and Extrahepatic Biliary Tract: A Framework for Understanding Congenital Diseases.肝内外胆管发育:先天性疾病理解的框架。
Annu Rev Pathol. 2020 Jan 24;15:1-22. doi: 10.1146/annurev-pathmechdis-012418-013013. Epub 2019 Jul 12.
10
Recurrence After Resection for Intraductal Papillary Neoplasm of Bile Duct (IPNB) According to Tumor Location.根据肿瘤位置的不同,胆管内乳头状肿瘤(IPNB)切除后的复发情况。
J Gastrointest Surg. 2020 Apr;24(4):804-812. doi: 10.1007/s11605-019-04235-8. Epub 2019 May 6.